Shopping Cart
- Remove All
Your shopping cart is currently empty
EPI-7170 is a ralaniten analogue and a potent antagonist of the androgen receptor N-terminal structural domain, blocking the transcriptional activity of the full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 exhibits antitumor activity against enzalutamide resistant debulking resistant prostate cancer (CRPC).

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $931 | 8-10 weeks | |
| 50 mg | $1,210 | 8-10 weeks | |
| 100 mg | $1,940 | 8-10 weeks |
| Description | EPI-7170 is a ralaniten analogue and a potent antagonist of the androgen receptor N-terminal structural domain, blocking the transcriptional activity of the full-length AR (FL-AR) and AR splice variants (AR-Vs). EPI-7170 exhibits antitumor activity against enzalutamide resistant debulking resistant prostate cancer (CRPC). |
| Molecular Weight | 540.88 |
| Formula | C22H28Cl3NO6S |
| Cas No. | 2139288-26-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.